Edwin P. Alyea
About
Edwin P. Alyea is a scholar working on Hematology, Immunology and Oncology.
According to data from OpenAlex, Edwin P. Alyea has authored 293 papers receiving a total of 15.7k indexed citations (citations by other indexed papers that have themselves been cited), including 235 papers in Hematology, 109 papers in Immunology and 76 papers in Oncology. Recurrent topics in Edwin P. Alyea's work include Hematopoietic Stem Cell Transplantation (196 papers), Acute Myeloid Leukemia Research (63 papers) and T-cell and B-cell Immunology (59 papers). Edwin P. Alyea is often cited by papers focused on Hematopoietic Stem Cell Transplantation (196 papers), Acute Myeloid Leukemia Research (63 papers) and T-cell and B-cell Immunology (59 papers). Edwin P. Alyea collaborates with scholars based in United States, Canada and Germany. Edwin P. Alyea's co-authors include Robert J. Soiffer, Joseph H. Antin, Vincent T. Ho, Corey Cutler, Jerome Ritz, Haesook T. Kim, John Koreth, Philippe Armand, Stephanie J. Lee and Donna Neuberg and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Clinical Investigation.
In The Last Decade
Edwin P. Alyea
286 papers receiving 15.5k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Edwin P. Alyea United States | 72 | 10.6k | 6.8k | 4.1k | 2.4k | 2.3k | 293 | 15.7k | ||
| Vincent T. Ho United States | 65 | 10.4k 1.0× | 5.8k 0.9× | 3.4k 0.8× | 2.1k 0.9× | 2.3k 1.0× | 323 | 14.9k | ||
| Corey Cutler United States | 73 | 13.1k 1.2× | 6.8k 1.0× | 4.0k 1.0× | 3.2k 1.4× | 3.1k 1.4× | 449 | 18.2k | ||
| Didier Blaise France | 60 | 12.1k 1.1× | 5.1k 0.8× | 5.0k 1.2× | 2.1k 0.9× | 3.7k 1.7× | 652 | 16.5k | ||
| Jeff Szer Australia | 58 | 8.4k 0.8× | 4.8k 0.7× | 3.5k 0.8× | 3.2k 1.3× | 1.9k 0.9× | 385 | 15.3k | ||
| Todd E. DeFor United States | 62 | 10.1k 0.9× | 6.5k 1.0× | 5.1k 1.2× | 2.9k 1.2× | 1.8k 0.8× | 297 | 15.7k | ||
| Donna Przepiorka United States | 59 | 12.0k 1.1× | 5.6k 0.8× | 5.5k 1.3× | 3.0k 1.3× | 2.6k 1.1× | 197 | 18.2k | ||
| Marcos de Lima United States | 62 | 9.2k 0.9× | 2.9k 0.4× | 3.5k 0.9× | 2.3k 1.0× | 2.8k 1.3× | 421 | 12.7k | ||
| Richard T. Maziarz United States | 59 | 7.5k 0.7× | 2.6k 0.4× | 4.0k 1.0× | 2.5k 1.1× | 2.3k 1.0× | 361 | 13.1k | ||
| Myriam Labopin France | 63 | 12.3k 1.2× | 3.1k 0.5× | 3.6k 0.9× | 2.0k 0.9× | 4.8k 2.1× | 510 | 15.2k | ||
| Nicolaus Kröger Germany | 70 | 12.0k 1.1× | 3.4k 0.5× | 5.1k 1.2× | 3.9k 1.6× | 2.7k 1.2× | 583 | 17.0k |
Countries citing papers authored by Edwin P. Alyea
Since
Specialization
Citations
This map shows the geographic impact of Edwin P. Alyea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edwin P. Alyea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edwin P. Alyea more than expected).
Fields of papers citing papers by Edwin P. Alyea
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Edwin P. Alyea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edwin P. Alyea. The network helps show where Edwin P. Alyea may publish in the future.
Co-authorship network of co-authors of Edwin P. Alyea
This figure shows the co-authorship network connecting the top 25 collaborators of Edwin P. Alyea. A scholar is included among the top collaborators of Edwin P. Alyea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edwin P. Alyea. Edwin P. Alyea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Kekre, Natasha, Haesook T. Kim, Vincent T. Ho, et al.. (2020). Phase II trial of natalizumab with corticosteroids as initial treatment of gastrointestinal acute graft-versus-host disease. Bone Marrow Transplantation. 56(5). 1006–1012.
2.
Kim, Haesook T., Lindsey E. Roeker, Corey Cutler, et al.. (2019). Incidence, Predictors, and Outcomes of Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome after Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(3). 529–539.
3.
Magenau, John, Steven C. Goldstein, Robert J. Soiffer, et al.. (2018). α1-Antitrypsin infusion for treatment of steroid-resistant acute graft-versus-host disease. Blood. 131(12). 1372–1379.
4.
Kim, Haesook T., Jiqiao Yang, Robert J. Soiffer, et al.. (2018). Impact of Thrombotic Microangiopathy on Renal Outcomes and Survival after Hematopoietic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation. 24(11). 2344–2353.
5.
Kamihara, Yusuke, Édouard Forcade, John Koreth, et al.. (2017). Low-Dose Interleukin-2 Therapy Activates Circulating T Follicular Regulatory Cells and Suppresses Circulating T Follicular Helper Cells in Patients with Chronic Gvhd. Blood. 130(Suppl_1). 74–74.
6.
Berg, David D., Muthiah Vaduganathan, Matthew S. Davids, et al.. (2017). Immune-Related Fulminant Myocarditis in a Patient Receiving Ipilimumab Therapy for Relapsed Chronic Myelomonocytic Leukaemia. European Journal of Heart Failure. 19(5). 682–685.
7.
Forcade, Édouard, Yusuke Kamihara, Haesook T. Kim, et al.. (2017). T Follicular Regulatory (TFR) Cell Deficiency during Chronic Graft-Versus-Host Disease Is Improved By Low-Dose IL-2 Therapy. Blood. 130. 4439–4439.
8.
Piesche, Matthias, Vincent T. Ho, Haesook Kim, et al.. (2014). Angiogenic Cytokines Are Antibody Targets During Graft-versus-Leukemia Reactions. Clinical Cancer Research. 21(5). 1010–1018.
9.
Koreth, John, Kristen E. Stevenson, Haesook T. Kim, et al.. (2012). Bortezomib-Based Graft-Versus-Host Disease Prophylaxis in HLA-Mismatched Unrelated Donor Transplantation. Journal of Clinical Oncology. 30(26). 3202–3208.
10.
Bishop, Michael, Edwin P. Alyea, Mitchell S. Cairo, et al.. (2011). National Cancer Institute’s First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: Summary and Recommendations from the Organizing Committee. Biology of Blood and Marrow Transplantation. 17(4). 443–454.
11.
Zhang, Wandi, Wanyong Zeng, Shelby A. Rogers, et al.. (2010). Graft-versus-Leukemia Antigen CML66 Elicits Coordinated B-Cell and T-Cell Immunity after Donor Lymphocyte Infusion. Clinical Cancer Research. 16(10). 2729–2739.
12.
Biernacki, Melinda A., Ovidiu Marina, Wandi Zhang, et al.. (2010). Efficacious Immune Therapy in Chronic Myelogenous Leukemia (CML) Recognizes Antigens That Are Expressed on CML Progenitor Cells. Cancer Research. 70(3). 906–915.
13.
Marina, Ovidiu, Ursula Hainz, Melinda A. Biernacki, et al.. (2010). Serologic Markers of Effective Tumor Immunity against Chronic Lymphocytic Leukemia Include Nonmutated B-Cell Antigens. Cancer Research. 70(4). 1344–1355.
14.
Cutler, Corey, Haesook T. Kim, Gary Bradwin, et al.. (2010). Prediction of Veno-Occlusive Disease Using Biomarkers of Endothelial Injury. Biology of Blood and Marrow Transplantation. 16(8). 1180–1185.
15.
Alyea, Edwin P., Daniel J. DeAngelo, John M. Pagel, et al.. (2010). NCI First International Workshop on the Biology, Prevention and Treatment of Relapse after Allogeneic Hematopoietic Cell Transplantation: Report from the Committee on Prevention of Relapse Following Allogeneic Cell Transplantation for Hematologic Malignancies. Biology of Blood and Marrow Transplantation. 16(8). 1037–1069.
16.
Armand, Philippe, Haesook T. Kim, Corey Cutler, et al.. (2008). Improved Survival in Lymphoma Patients Receiving Sirolimus for Graft-Versus-Host Disease Prophylaxis After Allogeneic Hematopoietic Stem-Cell Transplantation With Reduced-Intensity Conditioning. Journal of Clinical Oncology. 26(35). 5767–5774.
17.
Armand, Philippe, Haesook T. Kim, Corey Cutler, et al.. (2007). Prognostic impact of elevated pretransplantation serum ferritin in patients undergoing myeloablative stem cell transplantation. Blood. 109(10). 4586–4588.
18.
Cutler, Corey, Vincent T. Ho, Edwin P. Alyea, et al.. (2005). Oral mucositis incidence and severity after methotrexate- and non-methotrexate-containing GVHD prophylaxis regimens. Biology of Blood and Marrow Transplantation. 11(2). 3–3.
19.
Miklos, David B., Haesook T. Kim, Katherine H. Miller, et al.. (2004). Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission. Blood. 105(7). 2973–2978.
20.
Claret, Emmanuel, Edwin P. Alyea, Enrica Orsini, et al.. (1997). Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion.. Journal of Clinical Investigation. 100(4). 855–866.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Vincent T. Ho Breakdown of academic impact, for papers by Corey Cutler Breakdown of academic impact, for papers by Didier Blaise Breakdown of academic impact, for papers by Jeff Szer Breakdown of academic impact, for papers by Todd E. DeFor Breakdown of academic impact, for papers by Donna Przepiorka Breakdown of academic impact, for papers by Marcos de Lima Breakdown of academic impact, for papers by Richard T. Maziarz Breakdown of academic impact, for papers by Myriam Labopin Breakdown of academic impact, for papers by Nicolaus Kröger